Bafna Pharmaceuticals Limited has submitted a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2026. This certificate was received from the company's Registrar and Share Transfer Agent (RTA), M/s. Cameo Corporate Services Limited. The RTA confirmed that securities received from depository participants for dematerialisation during the quarter were processed and confirmed to the depositories. They also verified that the dematerialised securities are listed on the stock exchanges where the company's securities are already listed. Furthermore, Cameo Corporate Services Limited confirmed that the security certificates received for dematerialisation were duly verified, mutilated, and cancelled. The name of the depositories has been substituted in the register of members as the registered owner within the stipulated time limit, adhering to the SEBI regulations.
